BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2954994)

  • 1. D-Trp6-luteinizing hormone-releasing hormone inhibits sulpiride-induced hyperprolactinemia in normal men.
    Rubio MA; Torres-Aleman I; Calle JR; Cabranes JA; Schally AV; Charro AL
    J Clin Endocrinol Metab; 1987 Aug; 65(2):368-9. PubMed ID: 2954994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The luteinizing hormone-releasing hormone (LHRH) agonist [D-Trp6-Pro9-NEt]LHRH increased rather than lowered LH and alpha-subunit levels in a patient with an LH-secreting pituitary tumor.
    Roman SH; Goldstein M; Kourides IA; Comite F; Bardin CW; Krieger DT
    J Clin Endocrinol Metab; 1984 Feb; 58(2):313-9. PubMed ID: 6198331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. D-Trp-6-luteinizing hormone-releasing hormone inhibits hyperprolactinemia in female rats.
    Debeljuk L; Torres-Alemán I; Schally AV
    Endocrinology; 1985 Jun; 116(6):2227-31. PubMed ID: 3158510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pituitary and testicular response to luteinizing hormone releasing hormone in normal and sulpiride-induced hyperprolactinaemic men.
    Nakano R; Yagi S; Nishi T
    Exp Clin Endocrinol; 1988 May; 91(2):191-6. PubMed ID: 3137082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gonadotropin and alpha-subunit responses to chronic gonadotropin-releasing hormone analog administration in patients with glycoprotein hormone-secreting pituitary tumors.
    Klibanski A; Jameson JL; Biller BM; Crowley WF; Zervas NT; Rivier J; Vale WW; Bikkal H
    J Clin Endocrinol Metab; 1989 Jan; 68(1):81-6. PubMed ID: 2535852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolactin-lowering effect of luteinizing hormone-releasing hormone agonist administration in prolactinoma patients.
    Rubio MA; Cabranes JA; Schally AV; Charro AL
    J Clin Endocrinol Metab; 1989 Aug; 69(2):444-7. PubMed ID: 2526819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maintenance of the ratio of bioactive to immunoreactive follicle-stimulating hormone in normal men during chronic luteinizing hormone-releasing hormone agonist administration.
    Pavlou SN; Dahl KD; Wakefield G; Rivier J; Vale W; Hsueh AJ; Lindner J
    J Clin Endocrinol Metab; 1988 May; 66(5):1005-9. PubMed ID: 2834409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of [D-Trp6]LHRH infusion on prolactin secretion by perifused rat pituitary cells.
    Torres-Aleman I; Fernández M; Debeljuk L; Charro AL
    Regul Pept; 1987 Jul; 18(1):19-28. PubMed ID: 2957725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gonadotropin and steroid secretory patterns during chronic treatment with a luteinizing hormone-releasing hormone agonist analog in men.
    Evans RM; Doelle GC; Alexander AN; Uderman HD; Rabin D
    J Clin Endocrinol Metab; 1984 May; 58(5):862-7. PubMed ID: 6423661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of pituitary-testicular function with [D-Trp6] luteinizing hormone-releasing hormone in rhesus monkeys.
    Sundaram K; Connell KG; Bardin CW; Samojlik E; Schally AV
    Endocrinology; 1982 Apr; 110(4):1308-14. PubMed ID: 6460610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intermittent long-term administration of a potent gonadotropin-releasing hormone agonist in normal men.
    Doelle G; Linde R; Alexander N; Kirchner F; Vale W; Rivier J; Rabin D
    Int J Fertil; 1982; 27(4):234-7. PubMed ID: 6131043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long term treatment of male and female precocious puberty by periodic administration of a long-acting preparation of D-Trp6-luteinizing hormone-releasing hormone microcapsules.
    Roger M; Chaussain JL; Berlier P; Bost M; Canlorbe P; Colle M; Francois R; Garandeau P; Lahlou N; Morel Y
    J Clin Endocrinol Metab; 1986 Apr; 62(4):670-7. PubMed ID: 2936759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the luteinizing hormone-releasing hormone (LHRH) analog D-Trp6-Pro9-NEt-LHRH on the pituitary-gonadal axis of prepubertal rhesus monkeys.
    Cassorla F; Renquist D; Barnard D; Munabi AK; Cutler GB; Loriaux DL
    Biol Reprod; 1984 Jun; 30(5):1130-4. PubMed ID: 6428479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic administration of the luteinizing hormone-releasing hormone (LHRH) antagonist cetrorelix decreases gonadotrope responsiveness and pituitary LHRH receptor messenger ribonucleic acid levels in rats.
    Pinski J; Lamharzi N; Halmos G; Groot K; Jungwirth A; Vadillo-Buenfil M; Kakar SS; Schally AV
    Endocrinology; 1996 Aug; 137(8):3430-6. PubMed ID: 8754771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of prostate tumor growth in two rat models by chronic administration of D-Trp6 analogue of luteinizing hormone-releasing hormone.
    Redding TW; Schally AV
    Proc Natl Acad Sci U S A; 1981 Oct; 78(10):6509-12. PubMed ID: 6458815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of pituitary-testicular axis suppression in utero and during the early neonatal period with a long-acting luteinizing hormone-releasing hormone analog on genital development, somatic growth, and bone density in male cynomolgus monkeys in the first 6 months of life.
    Liu L; Cristiano AM; Southers JL; Reynolds JC; Bacher J; Brown G; Gilley RM; Tice TR; Banks SM; Loriaux LD
    J Clin Endocrinol Metab; 1991 Nov; 73(5):1038-43. PubMed ID: 1939516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen feedback in normal and sulpiride-induced hyperprolactinemic postmenopausal women.
    Nishi T; Nakano R; Yagi S
    Horm Res; 1989; 32(5-6):193-7. PubMed ID: 2517493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of experimental hyperprolactinemia and clomiphene on pituitary responsiveness to LHRH and TRH in men.
    Rönnberg L; Reinilä M; Ylikorkala O
    Andrologia; 1985; 17(4):364-8. PubMed ID: 3931501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphological studies of the canine pituitary luteinizing hormone (LH) cells after long-term treatment with the LH-releasing hormone (LHRH) agonist [D-Trp6]LHRH ethylamide.
    Dubé D; Pelletier G; Labrie F
    Endocrinology; 1987 Feb; 120(2):589-94. PubMed ID: 3542506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mode of suppression of pituitary and gonadal function after acute or prolonged administration of a luteinizing hormone-releasing hormone antagonist in normal men.
    Pavlou SN; Wakefield G; Schlechter NL; Lindner J; Souza KH; Kamilaris TC; Konidaris S; Rivier JE; Vale WW; Toglia M
    J Clin Endocrinol Metab; 1989 Feb; 68(2):446-54. PubMed ID: 2537334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.